China’s Syneron raises $150M for peptides, adding to last year’s $100Mnews2026-04-06T10:50:19+00:00April 6th, 2026|Endpoints News|
To counter China, FDA chief wants to speed new drug trial processnews2026-04-01T19:15:42+00:00April 1st, 2026|Endpoints News|
Eli Lilly to pay $115M upfront to Insilico in AI drug discovery dealnews2026-03-30T14:07:39+00:00March 30th, 2026|Endpoints News|
#ACC26: Braveheart Bio’s Hengrui-originated pill posts China data in heart muscle diseasenews2026-03-30T13:30:46+00:00March 30th, 2026|Endpoints News|
AstraZeneca’s in vivo CAR-T led to early responses, but one death in China trialnews2026-03-27T12:00:35+00:00March 27th, 2026|Endpoints News|
Top HHS official makes impassioned pitch to take on China biotechnews2026-03-27T05:00:45+00:00March 27th, 2026|Endpoints News|
Oral peptides biotech Pinnacle Medicines gets $89M from US, China investorsnews2026-03-26T11:30:18+00:00March 26th, 2026|Endpoints News|
Novartis to invest $480M in China following AstraZeneca and Lilly pledgesnews2026-03-23T18:40:53+00:00March 23rd, 2026|Endpoints News|
WuXi AppTec’s bet on the US pays off as revenues dip elsewherenews2026-03-23T15:24:18+00:00March 23rd, 2026|Endpoints News|
China-rooted AI biotech Earendil Labs raises $787M ahead of possible IPOnews2026-03-20T15:16:10+00:00March 20th, 2026|Endpoints News|
